The digital health explosion has seen many different segments of solutions emerge. For digital therapeutics, most to date have been positioned as consumer-facing solutions that see them provide interventions directly to patients. These types of solutions may then link to other systems, like electronic medical records in hospitals and clinics, to provide a more rounded and joined-up picture of care.

“While they are two very distinct systems, we are seeing increasing interoperability between digital therapeutic solutions and electronic medical records. It is important that these work synergistically to provide the maximum benefit for the patient,” Pierre says.

The barrier to entry for new companies and new solutions seems, at least at first glance, to be relatively low. Consequently, there are a lot of newcomers to the industry. But, Pierre says, appearances can be deceptive. “People do not necessarily realise what degree of investment and effort is needed to bring a digital therapeutic product to market.”

Now, supported by the growing levels of clinical evidence and outcomes, digital therapeutics are being increasingly recognised as a legitimate category and solution in the healthcare industry.